Showing results (321-330 of 447) with videos related to
Sort By:
Pageof 45
Cardio-Oncology (London, England)|June 19, 2026
Temporal trends and forecasted mortality involving lung cancer with co-listed hypertension in U.S. adults, 2000-2035Syeda Samia Fatima, Asma Naz, Muneeb Fareed, et al.Cardio-Oncology (London, England)|July 5, 2026
Temporal dynamics of cardiac biomarkers in therapy‑related cardiotoxicity: a prospective cardio‑oncology cohort studyLidia Anca Kajanto, Dana Lucia Stănculeanu, Anca Chisoi, et al.Cardio-Oncology (London, England)|July 8, 2026
Burden of cardiovascular diseases in breast cancer survivors: a 9-year retrospective cohort study based on regional medical data in Inner Mongolia ChinaQiaorui Wen, Yunjing Zhang, Liying Qiao, et al.Cardio-Oncology (London, England)|July 21, 2026
Interpretable machine learning for cardiovascular disease risk prediction in cancer survivors: development and internal validationGuoxing Zhang, Xueying Zhang, Chunyi Jia, et al.Cardio-Oncology (London, England)|September 11, 2026
Coronary artery calcification score as a prognostic factor in patients undergoing allogeneic stem cell transplantation - a retrospective analysisHans-Jonas Meyer, Anar Aghayev, Narmin Nasibova, et al.Cardio-Oncology (London, England)|October 9, 2026
Cardio-oncology from the consulting side: diagnostic thresholds, surveillance and treatment responsibility among cardiologists and internists in a German multicentre surveySebastian Poley, Lorena Payo-Anez, Felix M Heidrich, et al.Cardio-Oncology (London, England)|October 9, 2026
Complex cardiac overlap: immune checkpoint inhibitor myocarditis in hypertrophic obstructive cardiomyopathy with subsequent NSTEMIAhmed Basuoni, Marwa Makhlouf, Waleed Dawelbeit, et al.Cardio-Oncology (London, England)|November 24, 2022
Outcomes of malignancy in adults with congenital heart disease: a single center experiencePrashanth Venkatesh, Kimberly L Yan, Katia Bravo-Jaimes, et al.Cardio-Oncology (London, England)|October 14, 2021
Sacubitril/valsartan is well tolerated in patients with longstanding heart failure and history of cancer and improves ventricular function: real-world dataMaria Klara Frey, Henrike Arfsten, Noemi Pavo, et al.Cardio-Oncology (London, England)|August 1, 2017
The interplay between genetic background and sexual dimorphism of doxorubicin-induced cardiotoxicityBeshay N Zordoky, M Judith Radin, Lois Heller, et al.Pageof 45